di-beta-(morpholinoethyl)selenide has been researched along with ketamine in 1 studies
Studies (di-beta-(morpholinoethyl)selenide) | Trials (di-beta-(morpholinoethyl)selenide) | Recent Studies (post-2010) (di-beta-(morpholinoethyl)selenide) | Studies (ketamine) | Trials (ketamine) | Recent Studies (post-2010) (ketamine) |
---|---|---|---|---|---|
20 | 1 | 14 | 15,029 | 2,321 | 6,678 |
Protein | Taxonomy | di-beta-(morpholinoethyl)selenide (IC50) | ketamine (IC50) |
---|---|---|---|
Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) | 4.216 | |
Glutamate receptor ionotropic, NMDA 2A | Rattus norvegicus (Norway rat) | 4.216 | |
Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | 5.02 | |
Glutamate receptor ionotropic, NMDA 2C | Rattus norvegicus (Norway rat) | 5.02 | |
Glutamate receptor ionotropic, NMDA 1 | Homo sapiens (human) | 3.7762 | |
Glutamate receptor ionotropic, NMDA 2A | Homo sapiens (human) | 3.5563 | |
Glutamate receptor ionotropic, NMDA 2B | Homo sapiens (human) | 4.1059 | |
Glutamate receptor ionotropic, NMDA 2D | Rattus norvegicus (Norway rat) | 5.02 | |
Glutamate receptor ionotropic, NMDA 3B | Rattus norvegicus (Norway rat) | 5.02 | |
Glutamate receptor ionotropic, NMDA 3A | Rattus norvegicus (Norway rat) | 5.02 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Billings, J; Blau, M; Farrell, E; Kung, HF | 1 |
1 other study(ies) available for di-beta-(morpholinoethyl)selenide and ketamine
Article | Year |
---|---|
The effect of anaesthetics on the uptake of brain-imaging agents in rats.
Topics: Anesthetics; Animals; Autoradiography; Brain; Ether; Halothane; Iodobenzenes; Ketamine; Male; Morpholines; Organoselenium Compounds; Pentobarbital; Rats; Rats, Inbred Strains; Selenium; Urethane | 1985 |